CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
25.50
-0.75 (-2.86%)
At close: Mar 3, 2026
Market Cap5.46B -50.6%
Revenue (ttm)3.21M +196.7%
Net Income-230.38M
EPS-1.08
Shares Out214.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume464,663
Average Volume331,653
Open26.25
Previous Close26.25
Day's Range24.95 - 26.25
52-Week Range24.95 - 62.40
Beta-0.51
RSI33.65
Earnings DateMar 23, 2026

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements